New Day Therapeutics Overview

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

New Day Therapeutics General Information

Description

Operator of an app-based patient management platform intended to support the treatment of PTSD and depression with ketamine therapy. The company's platform provides a secure portal for healthcare providers to oversee patient treatment, track symptoms, and manage dosages, enabling healthcare providers to safely and efficiently manage patients receiving this therapy and to intervene in advance of a crisis.

Contact Information

Website
newdaythera.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Granville, OH 43023
  • United States
Primary Industry
Other Healthcare Technology Systems
Other Industries
Clinics/Outpatient Services
Vertical(s)
Corporate Office
  • Granville, OH 43023
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

New Day Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 12-Sep-2025 Completed Startup
To view New Day Therapeutics’s complete valuation and funding history, request access »

New Day Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Caduceus Capital Partners Venture Capital Minority
To view New Day Therapeutics’s complete investors history, request access »

New Day Therapeutics FAQs

  • Where is New Day Therapeutics headquartered?

    New Day Therapeutics is headquartered in Granville, OH.

  • What industry is New Day Therapeutics in?

    New Day Therapeutics’s primary industry is Other Healthcare Technology Systems.

  • Is New Day Therapeutics a private or public company?

    New Day Therapeutics is a Private company.

  • What is New Day Therapeutics’s current revenue?

    The current revenue for New Day Therapeutics is .

  • Who are New Day Therapeutics’s investors?

    Caduceus Capital Partners has invested in New Day Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process